← Eichor
Study identifier: NCT07572357 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical Evaluation of the RH210 Hearing Aid

Condition: Hearing Impairment, Sensorineural · Perceived Hearing Loss  ·  Sponsor: Rehear Audiology Company LTD

PhaseNA
Planned participants24
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The RH210A is an air-conduction hearing aid designed for adults with perceived mild-to-moderate sensorineural hearing loss. The purpose of this clinical investigation is to generate objective and subjective evidence of the clinical performance and safety of the device.

This description comes directly from the study's public registry record.

Talk to the study team

Marisa Poulos, Master of Audiology  ·  +61 2 9412 6872  ·  marisa.poulos@nal.gov.au

Sanna Hou, Master of Audiology  ·  +61 2 9412 6872  ·  sann.hou@nal.gov.au

Always discuss trial participation with your own doctor first.

Locations (1)

National Acoustic LaboratoriesMacquarie Park, New South Wales, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07572357